These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31959204)

  • 1. A DNA methylation signature to improve survival prediction of gastric cancer.
    Peng Y; Wu Q; Wang L; Wang H; Yin F
    Clin Epigenetics; 2020 Jan; 12(1):15. PubMed ID: 31959204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methylation-driven gene panel predicts survival in patients with colon cancer.
    Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D
    FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
    Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
    Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
    Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
    Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
    Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
    J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
    Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
    Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of TNM staging and pathway based risk score models in patients with gastric cancer.
    Zhou YY; Kang YT; Chen C; Xu FF; Wang HN; Jin R
    J Cell Biochem; 2018 Apr; 119(4):3608-3617. PubMed ID: 29231991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer.
    Hu BL; Xie MZ; Li KZ; Li JL; Gui YC; Xu JW
    Biomed Pharmacother; 2019 Sep; 117():109159. PubMed ID: 31247467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
    Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
    Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
    Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
    Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.